2025-2031 Global Oral Solid Dosage CDMO Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Service & Software > 2025-2031 Global Oral Solid Dosage CDMO Industry Research & Trends Analysis Report

2025-2031 Global Oral Solid Dosage CDMO Industry Research & Trends Analysis Report

Publication Date: 2025-05-10
Report Id: 2089869
Industry: Service & Software
Report Page: 141
Chart: 141

PDF Download

Publication Date: 2025-05-10
Report Id: 2089869
Industry: Service & Software
Report Page: 141
Chart: 141

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of Oral Solid Dosage CDMO
1.2 Global Oral Solid Dosage CDMO Market Size and Forecast
1.3 China Oral Solid Dosage CDMO Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Oral Solid Dosage CDMO Share in Global Market, 2020-2031
1.4.2 Oral Solid Dosage CDMO Market Size: China VS Global, 2020-2031
1.5 Oral Solid Dosage CDMO Market Dynamics
1.5.1 Oral Solid Dosage CDMO Market Drivers
1.5.2 Oral Solid Dosage CDMO Market Restraints
1.5.3 Oral Solid Dosage CDMO Industry Trends
1.5.4 Oral Solid Dosage CDMO Industry Policy

2 Competitive Landscape by Company
2.1 Global Oral Solid Dosage CDMO Revenue by Company, 2020-2025
2.2 Global Oral Solid Dosage CDMO Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Oral Solid Dosage CDMO Concentration Ratio
2.4 Global Oral Solid Dosage CDMO Mergers & Acquisitions, Expansion Plans
2.5 Global Oral Solid Dosage CDMO Manufacturers Product Type
2.6 Global Geographic Distribution of Oral Solid Dosage CDMO Companies

3 China Competitive Situation by Company
3.1 China Oral Solid Dosage CDMO Revenue by Company, 2020-2025
3.2 China Oral Solid Dosage CDMO Oral Solid Dosage CDMO Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China Oral Solid Dosage CDMO Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis
4.1 Oral Solid Dosage CDMO Industry Chain
4.2 Oral Solid Dosage CDMO Upstream Analysis
4.3 Oral Solid Dosage CDMO Midstream Analysis
4.4 Oral Solid Dosage CDMO Downstream Analysis

5 Sights by Type
5.1 Oral Solid Dosage CDMO Classification
5.1.1 Chemical Drug CDMO
5.1.2 Biological Drug CDMO
5.2 by Type, Global Oral Solid Dosage CDMO Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Oral Solid Dosage CDMO Market Size, 2020-2031

6 Sights by Application
6.1 Oral Solid Dosage CDMO Segment by Application
6.1.1 Ordinary Oral Solid Preparations
6.1.2 High-Activity and Special Preparations
6.2 by Application, Global Oral Solid Dosage CDMO Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Oral Solid Dosage CDMO Market Size, 2020-2031

7 Sights by Region
7.1 By Region, Global Oral Solid Dosage CDMO Market Size, 2020 VS 2024 VS 2031
7.2 By Region, Global Oral Solid Dosage CDMO Market Size, 2020-2031
7.3 North America
7.3.1 North America Oral Solid Dosage CDMO Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Oral Solid Dosage CDMO Market Size Market Share
7.4 Europe
7.4.1 Europe Oral Solid Dosage CDMO Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Oral Solid Dosage CDMO Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Oral Solid Dosage CDMO Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Oral Solid Dosage CDMO Market Size Market Share
7.6 South America
7.6.1 South America Oral Solid Dosage CDMO Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Oral Solid Dosage CDMO Market Size Market Share
7.7 Middle East & Africa

8 Sights by Country Level
8.1 By Country, Global Oral Solid Dosage CDMO Market Size & CAGR，2020 VS 2024 VS 2031
8.2 By Country, Global Oral Solid Dosage CDMO Market Size, 2020-2031
8.3 United States
8.3.1 United States Oral Solid Dosage CDMO Market Size, 2020-2031
8.3.2 By Company, United States Oral Solid Dosage CDMO Revenue Market Share, 2024
8.3.3 by Type, United States Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.3.4 by Application, United States Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Oral Solid Dosage CDMO Market Size, 2020-2031
8.4.2 By Company, Europe Oral Solid Dosage CDMO Revenue Market Share, 2024
8.4.3 by Type, Europe Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.4.4 by Application, Europe Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.5 China
8.5.1 China Oral Solid Dosage CDMO Market Size, 2020-2031
8.5.2 By Company, China Oral Solid Dosage CDMO Revenue Market Share, 2024
8.5.3 by Type, China Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.5.4 by Application, China Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Oral Solid Dosage CDMO Market Size, 2020-2031
8.6.2 By Company, Japan Oral Solid Dosage CDMO Revenue Market Share, 2024
8.6.3 by Type, Japan Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.6.4 by Application, Japan Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Oral Solid Dosage CDMO Market Size, 2020-2031
8.7.2 By Company, South Korea Oral Solid Dosage CDMO Revenue Market Share, 2024
8.7.3 by Type, South Korea Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.7.4 by Application, South Korea Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Oral Solid Dosage CDMO Market Size, 2020-2031
8.8.2 By Company, Southeast Asia Oral Solid Dosage CDMO Revenue Market Share, 2024
8.8.3 by Type, Southeast Asia Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.8.4 by Application, Southeast Asia Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.9 India
8.9.1 India Oral Solid Dosage CDMO Market Size, 2020-2031
8.9.2 By Company, India Oral Solid Dosage CDMO Revenue Market Share, 2024
8.9.3 by Type, India Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.9.4 by Application, India Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Oral Solid Dosage CDMO Market Size, 2020-2031
8.10.2 By Company, Middle East & Africa Oral Solid Dosage CDMO Revenue Market Share, 2024
8.10.3 by Type, Middle East & Africa Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031
8.10.4 by Application, Middle East & Africa Oral Solid Dosage CDMO Revenue Market Share, 2024 VS 2031

9 Company Profile
9.1 Adragos Pharma
9.1.1 Adragos Pharma Company Information, Head Office, Market Area, and Industry Position
9.1.2 Adragos Pharma Company Profile and Main Business
9.1.3 Adragos Pharma Oral Solid Dosage CDMO Models, Specifications, and Application
9.1.4 Adragos Pharma Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.1.5 Adragos Pharma Recent Developments
9.2 Aenova
9.2.1 Aenova Company Information, Head Office, Market Area, and Industry Position
9.2.2 Aenova Company Profile and Main Business
9.2.3 Aenova Oral Solid Dosage CDMO Models, Specifications, and Application
9.2.4 Aenova Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.2.5 Aenova Recent Developments
9.3 Agno Pharma
9.3.1 Agno Pharma Company Information, Head Office, Market Area, and Industry Position
9.3.2 Agno Pharma Company Profile and Main Business
9.3.3 Agno Pharma Oral Solid Dosage CDMO Models, Specifications, and Application
9.3.4 Agno Pharma Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.3.5 Agno Pharma Recent Developments
9.4 Alcami
9.4.1 Alcami Company Information, Head Office, Market Area, and Industry Position
9.4.2 Alcami Company Profile and Main Business
9.4.3 Alcami Oral Solid Dosage CDMO Models, Specifications, and Application
9.4.4 Alcami Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.4.5 Alcami Recent Developments
9.5 Almac
9.5.1 Almac Company Information, Head Office, Market Area, and Industry Position
9.5.2 Almac Company Profile and Main Business
9.5.3 Almac Oral Solid Dosage CDMO Models, Specifications, and Application
9.5.4 Almac Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.5.5 Almac Recent Developments
9.6 Cambrex
9.6.1 Cambrex Company Information, Head Office, Market Area, and Industry Position
9.6.2 Cambrex Company Profile and Main Business
9.6.3 Cambrex Oral Solid Dosage CDMO Models, Specifications, and Application
9.6.4 Cambrex Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.6.5 Cambrex Recent Developments
9.7 Rubicon Research
9.7.1 Rubicon Research Company Information, Head Office, Market Area, and Industry Position
9.7.2 Rubicon Research Company Profile and Main Business
9.7.3 Rubicon Research Oral Solid Dosage CDMO Models, Specifications, and Application
9.7.4 Rubicon Research Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.7.5 Rubicon Research Recent Developments
9.8 Catalent Pharma Solutions
9.8.1 Catalent Pharma Solutions Company Information, Head Office, Market Area, and Industry Position
9.8.2 Catalent Pharma Solutions Company Profile and Main Business
9.8.3 Catalent Pharma Solutions Oral Solid Dosage CDMO Models, Specifications, and Application
9.8.4 Catalent Pharma Solutions Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.8.5 Catalent Pharma Solutions Recent Developments
9.9 Hetero
9.9.1 Hetero Company Information, Head Office, Market Area, and Industry Position
9.9.2 Hetero Company Profile and Main Business
9.9.3 Hetero Oral Solid Dosage CDMO Models, Specifications, and Application
9.9.4 Hetero Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.9.5 Hetero Recent Developments
9.10 Ind-Swift Laboratories
9.10.1 Ind-Swift Laboratories Company Information, Head Office, Market Area, and Industry Position
9.10.2 Ind-Swift Laboratories Company Profile and Main Business
9.10.3 Ind-Swift Laboratories Oral Solid Dosage CDMO Models, Specifications, and Application
9.10.4 Ind-Swift Laboratories Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.10.5 Ind-Swift Laboratories Recent Developments
9.11 Lonza
9.11.1 Lonza Company Information, Head Office, Market Area, and Industry Position
9.11.2 Lonza Company Profile and Main Business
9.11.3 Lonza Oral Solid Dosage CDMO Models, Specifications, and Application
9.11.4 Lonza Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.11.5 Lonza Recent Developments
9.12 PharmaSource
9.12.1 PharmaSource Company Information, Head Office, Market Area, and Industry Position
9.12.2 PharmaSource Company Profile and Main Business
9.12.3 PharmaSource Oral Solid Dosage CDMO Models, Specifications, and Application
9.12.4 PharmaSource Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.12.5 PharmaSource Recent Developments
9.13 Recipharm
9.13.1 Recipharm Company Information, Head Office, Market Area, and Industry Position
9.13.2 Recipharm Company Profile and Main Business
9.13.3 Recipharm Oral Solid Dosage CDMO Models, Specifications, and Application
9.13.4 Recipharm Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.13.5 Recipharm Recent Developments
9.14 Rottendorf Pharma
9.14.1 Rottendorf Pharma Company Information, Head Office, Market Area, and Industry Position
9.14.2 Rottendorf Pharma Company Profile and Main Business
9.14.3 Rottendorf Pharma Oral Solid Dosage CDMO Models, Specifications, and Application
9.14.4 Rottendorf Pharma Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.14.5 Rottendorf Pharma Recent Developments
9.15 Abbott
9.15.1 Abbott Company Information, Head Office, Market Area, and Industry Position
9.15.2 Abbott Company Profile and Main Business
9.15.3 Abbott Oral Solid Dosage CDMO Models, Specifications, and Application
9.15.4 Abbott Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.15.5 Abbott Recent Developments
9.16 Skyepharma
9.16.1 Skyepharma Company Information, Head Office, Market Area, and Industry Position
9.16.2 Skyepharma Company Profile and Main Business
9.16.3 Skyepharma Oral Solid Dosage CDMO Models, Specifications, and Application
9.16.4 Skyepharma Oral Solid Dosage CDMO Revenue and Gross Margin, 2020-2025
9.16.5 Skyepharma Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Oral Solid Dosage CDMO should grow from US$ 1722 million in 2024 to US$ 2679 million by 2031, with a CAGR of 6.0% for the period of 2025-2031.

Oral solid dosage CDMO (Contract Development and Manufacturing Organization) is a professional outsourcing model that provides pharmaceutical companies with a full chain of services from drug research and development, process development, pilot scale-up, clinical sample production to commercial production. Its core lies in helping customers shorten the R&D cycle, reduce production costs, and achieve rapid transformation of products from laboratory to market through the integration of technology platforms and production capabilities.

Oral Solid Dosage CDMO

According to YH Research, the global market for Oral Solid Dosage CDMO should grow from US$ 1722 million in 2024 to US$ 2679 million by 2031, with a CAGR of 6.0% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

China Oral Solid Dosage CDMO market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

The United States Oral Solid Dosage CDMO market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

In terms of product type, Chemical Drug CDMO segment holds a share about % in 2024, and will reach % in 2031; while in terms of end use, Ordinary Oral Solid Preparations has a share approximately % in 2024, and will grow at a CAGR % during 2025 and 2031.

The global key manufacturers of Oral Solid Dosage CDMO include Adragos Pharma, Aenova, Agno Pharma, Alcami, Almac, Cambrex, Rubicon Research, Catalent Pharma Solutions, Hetero, Ind-Swift Laboratories, etc. In 2024, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Oral Solid Dosage CDMO. Report Highlights:
(1) Global Oral Solid Dosage CDMO market size (value), history data from 2020-2024, and forecast data from 2025 to 2031.

(2) Global Oral Solid Dosage CDMO market competitive situation, revenue, and market share, from 2020 to 2024.

(3) China Oral Solid Dosage CDMO market competitive situation, revenue, and market share, from 2020 to 2024.

(4) Global Oral Solid Dosage CDMO segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Oral Solid Dosage CDMO segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Oral Solid Dosage CDMO industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    Chemical Drug CDMO
    Biological Drug CDMO

Market segment by Application, can be divided into
    Ordinary Oral Solid Preparations
    High-Activity and Special Preparations

Market segment by players, this report covers
    Adragos Pharma
    Aenova
    Agno Pharma
    Alcami
    Almac
    Cambrex
    Rubicon Research
    Catalent Pharma Solutions
    Hetero
    Ind-Swift Laboratories
    Lonza
    PharmaSource
    Recipharm
    Rottendorf Pharma
    Abbott
    Skyepharma